Policy

In part two of MJH Life Sciences’ three-part series, experts dissect President Trump’s most-favored nation executive order, warning that its use of tariffs and foreign price benchmarks could upend drug markets and test the limits of federal authority.

Deepika Srivastava of The Doctors Company discusses how AI is transforming medicine — and why physicians must stay engaged as the technology evolves.

Ohio State researchers say the billionaire entrepreneur’s Cost Plus Drug Company exposes how insurance premiums and middlemen drive up the true cost of neurologic medications.

Kyle Zebley, senior VP of the American Telemedicine Association, joins the show to talk about the expiration of Medicare’s telehealth flexibilities during the October 2025 federal government shutdown.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

As spending climbs and value plummets, Trilliant Health proposes hard questions to buck negative trends.

At the MGMA Leaders Conference 2025 in Orlando, Michael Blackman, M.D., MBA, chief medical officer of Greenway Health, sat down with Medical Economics to separate AI fact from fiction.

Michael Blackman, M.D., MBA, says rapid change and integration challenges still make adoption difficult for many practices.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

Kevin Schulman, M.D., MBA, professor of medicine at Stanford University, joins the show to talk about administrative burdens in health care.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert from the American Telemedicine Association offers his summary of what’s happening in Washington, D.C.

Feds highlight huge growth in spending on wound care and why it could be problematic in health care.

More than 1 million legally authorized workers may lose their jobs, raising new staffing and compliance challenges for independent practices.

Telehealth is effective — and potentially confusing for physicians and patients. Here’s how practices can avoid leaving patients behind.

At the MGMA Leaders Conference in Orlando, MGMA Government Affairs staff warned that a Sept. 30 lapse could stall key health extenders and deepen uncertainty. The shutdown is now here — here's what it means for physician practices.

Retroactive reimbursement, hospital at home are needed to ensure coverage during federal government shutdown.

Advocates say federal deadline, disagreement leave doctors, patients ‘dangling on the telehealth cliff.’